Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.494 | 0.840 | 7 | 22727026 | intron variant | C/G | snv | 0.71 |
|
Nervous System Diseases; Mental Disorders | 0.720 | 1.000 | 3 | 2012 | 2016 | |||||||
|
0.724 | 0.520 | 7 | 22728408 | intron variant | A/C;G | snv |
|
Skin and Connective Tissue Diseases; Cardiovascular Diseases | 0.720 | 1.000 | 2 | 2015 | 2019 | ||||||||
|
0.724 | 0.520 | 7 | 22728408 | intron variant | A/C;G | snv |
|
0.700 | 1.000 | 2 | 2016 | 2019 | |||||||||
|
7 | 22731677 | 3 prime UTR variant | G/A | snv | 7.2E-04 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||||
|
7 | 22731677 | 3 prime UTR variant | G/A | snv | 7.2E-04 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||||
|
7 | 22731677 | 3 prime UTR variant | G/A | snv | 7.2E-04 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||||
|
0.882 | 0.080 | 7 | 22728289 | intron variant | C/G | snv | 0.71 |
|
0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||
|
0.494 | 0.840 | 7 | 22727026 | intron variant | C/G | snv | 0.71 |
|
Neoplasms; Male Urogenital Diseases | 0.070 | 0.714 | 7 | 2009 | 2019 | |||||||
|
0.494 | 0.840 | 7 | 22727026 | intron variant | C/G | snv | 0.71 |
|
Nutritional and Metabolic Diseases; Endocrine System Diseases | 0.070 | 1.000 | 7 | 2006 | 2018 | |||||||
|
0.494 | 0.840 | 7 | 22727026 | intron variant | C/G | snv | 0.71 |
|
Neoplasms; Male Urogenital Diseases | 0.070 | 0.714 | 7 | 2009 | 2019 | |||||||
|
0.494 | 0.840 | 7 | 22727026 | intron variant | C/G | snv | 0.71 |
|
Nervous System Diseases; Cardiovascular Diseases | 0.060 | 0.833 | 6 | 2010 | 2019 | |||||||
|
0.494 | 0.840 | 7 | 22727026 | intron variant | C/G | snv | 0.71 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.060 | 1.000 | 6 | 2007 | 2017 | |||||||
|
0.494 | 0.840 | 7 | 22727026 | intron variant | C/G | snv | 0.71 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.060 | 1.000 | 6 | 2007 | 2017 | |||||||
|
0.494 | 0.840 | 7 | 22727026 | intron variant | C/G | snv | 0.71 |
|
Neoplasms | 0.050 | 1.000 | 5 | 2009 | 2017 | |||||||
|
0.494 | 0.840 | 7 | 22727026 | intron variant | C/G | snv | 0.71 |
|
Infections | 0.040 | 1.000 | 4 | 2018 | 2020 | |||||||
|
0.494 | 0.840 | 7 | 22727026 | intron variant | C/G | snv | 0.71 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications | 0.040 | 1.000 | 4 | 2017 | 2018 | |||||||
|
0.494 | 0.840 | 7 | 22727026 | intron variant | C/G | snv | 0.71 |
|
Cardiovascular Diseases | 0.040 | 1.000 | 4 | 2014 | 2019 | |||||||
|
0.494 | 0.840 | 7 | 22727026 | intron variant | C/G | snv | 0.71 |
|
Neoplasms | 0.040 | 0.750 | 4 | 2007 | 2018 | |||||||
|
0.494 | 0.840 | 7 | 22727026 | intron variant | C/G | snv | 0.71 |
|
Neoplasms | 0.040 | 0.750 | 4 | 2007 | 2018 | |||||||
|
0.494 | 0.840 | 7 | 22727026 | intron variant | C/G | snv | 0.71 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications | 0.040 | 1.000 | 4 | 2017 | 2018 | |||||||
|
0.494 | 0.840 | 7 | 22727026 | intron variant | C/G | snv | 0.71 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications | 0.040 | 1.000 | 4 | 2017 | 2018 | |||||||
|
0.555 | 0.760 | 7 | 22726627 | non coding transcript exon variant | G/C | snv | 9.9E-02 |
|
Nervous System Diseases; Cardiovascular Diseases | 0.040 | 1.000 | 4 | 2011 | 2017 | |||||||
|
0.555 | 0.760 | 7 | 22726627 | non coding transcript exon variant | G/C | snv | 9.9E-02 |
|
Digestive System Diseases; Neoplasms | 0.040 | 1.000 | 4 | 2012 | 2019 | |||||||
|
0.555 | 0.760 | 7 | 22726627 | non coding transcript exon variant | G/C | snv | 9.9E-02 |
|
Digestive System Diseases; Neoplasms | 0.040 | 1.000 | 4 | 2012 | 2019 | |||||||
|
0.555 | 0.760 | 7 | 22726627 | non coding transcript exon variant | G/C | snv | 9.9E-02 |
|
Nutritional and Metabolic Diseases; Endocrine System Diseases | 0.040 | 1.000 | 4 | 2006 | 2017 |